Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies
Wolfgang Löscher
Epilepsy Research (2016) Vol. 126, pp. 157-184
Closed Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Löscher, Heidrun Potschka, Sanjay M. Sisodiya, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 3, pp. 606-638
Open Access | Times Cited: 596
Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs
Wolfgang Löscher
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 1873-1888
Closed Access | Times Cited: 311
Commonalities in epileptogenic processes from different acute brain insults: Do they translate?
Pavel Klein, Raymond Dingledine, Eleonora Aronica, et al.
Epilepsia (2017) Vol. 59, Iss. 1, pp. 37-66
Open Access | Times Cited: 245
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
Wolfgang Löscher, Pavel Klein
CNS Drugs (2021) Vol. 35, Iss. 9, pp. 935-963
Open Access | Times Cited: 207
Structural, Molecular, and Functional Alterations of the Blood-Brain Barrier during Epileptogenesis and Epilepsy: A Cause, Consequence, or Both?
Wolfgang Löscher, Alon Friedman
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 591-591
Open Access | Times Cited: 182
Genetic testing and counseling for the unexplained epilepsies: An evidence‐based practice guideline of the National Society of Genetic Counselors
Lacey Smith, Jennifer Malinowski, Sophia Ceulemans, et al.
Journal of Genetic Counseling (2022) Vol. 32, Iss. 2, pp. 266-280
Open Access | Times Cited: 69
Oxidative Stress and Neurodegeneration in Animal Models of Seizures and Epilepsy
Krzysztof Łukawski, Stanisław J. Czuczwar
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1049-1049
Open Access | Times Cited: 45
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Wolfgang Löscher, Michel Gillard, Zara A. Sands, et al.
CNS Drugs (2016) Vol. 30, Iss. 11, pp. 1055-1077
Open Access | Times Cited: 143
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2020) Vol. 61, Iss. 11, pp. 2340-2364
Open Access | Times Cited: 136
The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP)
John H. Kehne, Brian D. Klein, Shamsi Raeissi, et al.
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 1894-1903
Open Access | Times Cited: 123
The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments
Wolfgang Löscher
Neuropharmacology (2019) Vol. 167, pp. 107605-107605
Closed Access | Times Cited: 123
Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Wolfgang Löscher
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 84
PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability
Tanveer Singh, Awanish Mishra, Rajesh Kumar Goel
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1573-1590
Closed Access | Times Cited: 65
Dogs as a Natural Animal Model of Epilepsy
Wolfgang Löscher
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 40
Serotonin receptors in epilepsy: Novel treatment targets?
Jo Sourbron, Lieven Lagae
Epilepsia Open (2022) Vol. 7, Iss. 2, pp. 231-246
Open Access | Times Cited: 38
Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments
Wolfgang Löscher, H. Steve White
Cells (2023) Vol. 12, Iss. 9, pp. 1233-1233
Open Access | Times Cited: 33
Development and pharmacologic characterization of the rat 6 Hz model of partial seizures
Cameron S. Metcalf, Peter J. West, Kyle Thomson, et al.
Epilepsia (2017) Vol. 58, Iss. 6, pp. 1073-1084
Open Access | Times Cited: 78
The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy
Claudia Brandt, Petra Hillmann, Andreas Noack, et al.
Neuropharmacology (2018) Vol. 140, pp. 107-120
Closed Access | Times Cited: 76
The relevance of inter- and intrastrain differences in mice and rats and their implications for models of seizures and epilepsy
Wolfgang Löscher, Russell J. Ferland, Thomas N. Ferraro
Epilepsy & Behavior (2017) Vol. 73, pp. 214-235
Open Access | Times Cited: 68
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening
Melissa Barker‐Haliski, H. Steve White
Neuropharmacology (2019) Vol. 167, pp. 107750-107750
Open Access | Times Cited: 62
Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation
Leanne M Lehmann, Alexandria Lo, Kevin M. Knox, et al.
Neurochemical Research (2021) Vol. 46, Iss. 8, pp. 1895-1912
Open Access | Times Cited: 42
Utility of Exome Sequencing for Diagnosis in Unexplained Pediatric-Onset Epilepsy
Hyun Yong Koh, Lacey Smith, Kimberly Wiltrout, et al.
JAMA Network Open (2023) Vol. 6, Iss. 7, pp. e2324380-e2324380
Open Access | Times Cited: 20
MicroRNA-induced silencing in epilepsy: Opportunities and challenges for clinical application
Durgesh Tiwari, Katrina Peariso, Christina Groß
Developmental Dynamics (2017) Vol. 247, Iss. 1, pp. 94-110
Open Access | Times Cited: 58
Methodological standards and interpretation of video‐electroencephalography in adult control rodents. A TASK 1‐ WG 1 report of the AES / ILAE Translational Task Force of the ILAE
Shilpa D. Kadam, Raimondo D’Ambrosio, Venceslas Duveau, et al.
Epilepsia (2017) Vol. 58, Iss. S4, pp. 10-27
Open Access | Times Cited: 57
Nose-to-brain delivery of levetiracetam after intranasal administration to mice
Joana Gonçalves, Joana Bicker, Filipa Gouveia, et al.
International Journal of Pharmaceutics (2019) Vol. 564, pp. 329-339
Closed Access | Times Cited: 53
Page 1 - Next Page

Scroll to top